Inventor · disambiguated record
Nicolas Gourdin
Also filed as: GOURDIN NICOLAS
5 granted patents·7 pending applications·8 citations·filing 2016–2025
72Inventor score
Top patents by PatentIndex Score
12 records- 0189US11377503B2Antibodies that bind human CD39 and inhibit ATPase activity of a soluble extracellular domain human CD39 polypeptideINNATE PHARMA·Filed 2019·Granted Jul 5, 2022·3 cites·13 claims
- 0286US12195555B2Natural killer (NK) cell engagers binding to NKp46 and BCMA variants with Fc-engineeringSANOFI SA·Filed 2023·Granted Jan 14, 2025·1 cites·33 claims
- 0383US11130817B2CD73 blocking agentsINNATE PHARMA·Filed 2016·Granted Sep 28, 2021·3 cites·5 claims
- 0479US12202907B2Nucleic acids encoding and methods of producing proteins comprising antibody chainsINNATE PHARMA·Filed 2022·Granted Jan 21, 2025·0 cites·36 claims
- 0577US11578136B2Compositions and methods for treating cancerINNATE PHARMA·Filed 2018·Granted Feb 14, 2023·1 cites·12 claims
- 0674US2025197528A1NATURAL KILLER (NK) CELL ENGAGERS BINDING TO NKp46 AND BCMA VARIANTS WITH FC-ENGINEERINGSANOFI SA·Filed 2024·Application pending·0 cites
- 0773US2023340143A1Compositions and methods for treating cancerINNATE PHARMA·Filed 2023·Application pending·0 cites
- 0871US2025236678A1Compositions and methods for treating cancerINNATE PHARMA·Filed 2025·Application pending·0 cites
- 0970US2023099801A1Restoration of t cell activity via the cd39/cd73 axisINNATE PHARMA·Filed 2022·Application pending·0 cites
- 1049US2019218308A1Restoration of t cell activity via the cd39/cd73 axisINNATE PHARMA·Filed 2019·Application pending·0 cites
- 1145US2019218304A1Potentiating the effect of atp releaseINNATE PHARMA·Filed 2019·Application pending·0 cites
- 1238US2020232974A1Lymphocytes expressing cd73 in cancerous patient dictates therapyCENTRE LEON BERARD·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Nicolas Gourdin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →